S. Walk

A US-based national surveillance study for the susceptibility and epidemiology of Clostridioides difficile isolates with special reference to ridinilazole: 2020–2021

L. Gluck, K. Garey, L. McDermott, 2023, Antimicrobial Agents and Chemotherapy.

Investigation of potentially pathogenic Clostridium difficile contamination in household environs.

M. Alam, Ananna Anu, S. Walk, 2014, Anaerobe.

Community Environmental Contamination of Toxigenic Clostridium difficile

K. Garey, J. Christensen, S. Walk, 2017, Open forum infectious diseases.

Evaluation of Portability and Cost of a Fluorescent PCR Ribotyping Protocol for Clostridium difficile Epidemiology

Egan J. Lohman, Krishna Rao, M. Khaleduzzaman, 2015, Journal of Clinical Microbiology.